For example, the immune checkpoint protein indoleamine 2,3-dioxygenase 1 (IDO) is overexpressed in many CRC patients and has been linked to tumour mediated immunosuppression and results in a poor prognosis. The gene discussed is IDO1; the disease is neoplasm.